Backed by IBM, the OpenPandemics project empowers anyone with a computer or smartphone to contribute idle processing power for vital COVID-19 research. This collective effort boosts virtual experiments, significantly advancing the search for effective treatments.Contribute to Cutting-Edge COVID-19 R

Led by a consortium of French companies and researchers, EasyCov is a groundbreaking saliva-based virological test for COVID-19. Set for market launch this summer following CE certification, this simple, practical, and fast screening method could transform detection—especially in Corsicas proposed G

Leading French researchers, including experts from Avicenne Hospital, reanalyzed archived PCR tests once ruled negative, uncovering the earliest confirmed COVID-19 case in Europe from December 27, 2019—weeks before Chinas WHO alert. Some evidence even suggests cases as far back as November, exposing

Researchers have discovered a close bat relative of SARS-CoV-2, providing strong evidence that the COVID-19 virus evolved naturally rather than in a lab. Claims of a lab leak from Wuhans P4 facility lack foundation. These high-security labs operate under extreme negative air pressure, ensuring patho

Years before COVID-19 emerged, Bill Gates warned global leaders about the dangers of highly infectious diseases—but few took action. For years, Bill Gates has sounded the alarm on the threat of a highly contagious virus. His most notable warning came over five years ago in a TED Talk, where he predi

Nearly a century old, the BCG vaccine against tuberculosis is sparking new hope in the fight against COVID-19. Researchers are testing its potential through clinical trials, but how might it help treat patients? Hematopoietic Stem Cells Offer Hope With about 27,000 deaths, France was among the harde

The novel coronavirus, first detected in humans months ago, may never go away, according to a senior World Health Organization (WHO) official. We must learn to live with it. SARS-CoV-2 has infected over 4.3 million people worldwide and claimed nearly 300,000 lives (official figures). Many hope it wi

Two recent studies reveal hydroxychloroquine provides no benefits in treating COVID-19, even in severe or milder cases. Chloroquine and its derivative hydroxychloroquine—drugs long used for malaria and autoimmune conditions—gained attention as potential COVID-19 therapies due to robust antiviral act

Caused by the SARS-CoV-2 virus, COVID-19 primarily triggers acute respiratory illness but manifests in a wide range of symptoms far beyond the lungs, as clinicians worldwide have documented since the pandemics onset. A Broad Spectrum of Symptoms Though the precise origin of COVID-19 in humans remain

For years, researchers at Columbia University have developed advanced ultraviolet (UV) lamp systems to eliminate dangerous viruses in public venues. These UV-C lamps are already proven in hospitals and food processing facilities. Powerful Yet Risky Germ-Killers Researchers propose deploying ultravio

Pangolins naturally host coronaviruses, but evidence does not support their role in transmitting SARS-CoV-2 to humans. Bats are likely the primary reservoir for SARS-CoV-2, the virus behind the COVID-19 pandemic. However, these viruses in bats lack the receptors needed to directly infect humans, poi

Vaccine development against COVID-19 is advancing rapidly, but experts are already debating the best rollout strategies. While scientists agree on the urgency, consensus on prioritization remains elusive. Who Should Be Prioritized? Leading research teams, including those at the University of Oxford

As COVID-19 cases surged across the U.S., many states halted executions. Missouri stood apart: Governor Mike Parson rejected postponement requests, scheduling the nations first execution amid the pandemic for May 19, 2020. Execution Moves Forward Despite Pandemic Risks By mid-May 2020, COVID-19 had

Like a lions mane shielding against rival attacks, human beards may have evolved to absorb punches to the face, according to recent research. Beards have long symbolized manhood across cultures, often viewed purely as aesthetic features. Even Charles Darwin, with his iconic facial hair, saw them as

Building an efficient open-source system for drug development is ethically compelling. Yet, from an economic standpoint, its far less appealing—especially for pharmaceutical labs. Is Open-Source Medicine a Pipe Dream? Imagine sharing research data freely to fast-track treatments for diseases—a dream

A team of researchers from Texas A&M University has pioneered a device that delivers targeted electrical impulses to surgeons fingers, enhancing control and success rates in robot-assisted procedures. Sensory Gloves with Precision Probes Even experienced surgeons can experience hand tremors during d

The COVID-19 pandemic has dealt a heavy blow to Europes tourism industry. EU Tourism Ministers recently convened via videoconference to devise strategies for this summer, prioritizing nations with the lowest infection rates. France, however, faces steeper hurdles. Rescuing the Summer Tourist Season

Researchers in Germany conducted autopsies on COVID-19 victims, revealing the virus persists in various organs up to five days post-mortem. Importantly, the low viral load indicates no transmission risk. Viral Presence in Multiple Organs SARS-CoV-2, the virus causing COVID-19, remains detectable in

The U.S. Federal Bureau of Investigation (FBI) has uncovered evidence of Chinese cyber espionage aimed at stealing sensitive data from American research on COVID-19 treatments. Technical details of these hacking attempts will be released by the FBI in the coming days. U.S. Accuses China of State-Spo

Stress affects us all at some point, often prompting reliance on medications or supplements for relief. Yet, simple breathing exercises offer a proven, natural way to regain control during anxiety episodes. Why Stress Makes Breathing Difficult During stress, respiratory discomfort arises and varies